Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

Parashar, 2009, Global mortality associated with rotavirus disease among children in 2004, J Infect Dis, 200, S9, 10.1086/605025 Bresee, 1999, Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries, Vaccine, 17, 2207, 10.1016/S0264-410X(98)00376-4 Vesikari, 2006, Safety and efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine in preventing rotavirus gastroenteritis and reducing associated health care resource utilization, N Engl J Med, 354, 23, 10.1056/NEJMoa052664 Ruis-Palacios, 2006, Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis, N Engl J Med, 345, 11, 10.1056/NEJMoa052434 Phua, 2009, Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomized, double-blind, controlled study, Vaccine, 48, 5936, 10.1016/j.vaccine.2009.07.098 2006, Conclusions and recommendations from the Immunization Strategic Advisory Group, Wkly Epidemiol Rec, 32, 2 DiStefano, 2005, Novel rotavirus VP7 typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and strain characterization, including serotype subgroup analysis, J Clin Microbiol, 43, 5876, 10.1128/JCM.43.12.5876-5880.2005 Ciarlet, 2008, Concomitant use of the oral pentavalent human bovine reassortant rotavirus vaccine and oral poliovirus vaccine, Pediatric Infect Dis J, 27, 874, 10.1097/INF.0b013e3181782780 Ward, 1997, Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial, J Infect Dis, 176, 570, 10.1086/514076 Knowlton, 1991, Development of an improved method for measuring neutralizing antibody to rotavirus, J Virol Methods, 33, 127, 10.1016/0166-0934(91)90013-P Ruuska, 1990, Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes, Scand J Infect Dis, 22, 259, 10.3109/00365549009027046 Chan, 1998, Exact power and sample size for vaccine efficacy studies, Commun Stat Theory Methods, 27, 1305, 10.1080/03610929808832160 Miettinen, 1985, Comparative analysis of two rates, Stat Med, 4, 213, 10.1002/sim.4780040211 Block, 2007, Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life, Pediatrics, 119, 11, 10.1542/peds.2006-2058 Vesikari, 2007, Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization based on data from 11 countries, International J Infect Dis, 11, S29, 10.1016/S1201-9712(07)60019-8 Ciarlet, 2009, Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq®, Vaccine, 27, G72, 10.1016/j.vaccine.2009.09.107 2008, 8 Health Statistics Report. Division of Health Statistics and Informatics, Department of Planning and Finance, Ministry of Health of Vietnam: Hanoi, Vietnam, 2005. 2007, Rotavirus vaccines, Wkly Epidemiol Rec, 82, 285 Vesikari, 2006, Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants, Vaccine, 24, 4821, 10.1016/j.vaccine.2006.03.025 Armah, 2010, Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial, Lancet, 10.1016/S0140-6736(10)60889-6 Patel, 2009, Oral rotavirus vaccines: how well will they work where they are needed most?, J Infect Dis, 200, S39, 10.1086/605035 Zaman, 2009, Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age, Vaccine, 27, 1333, 10.1016/j.vaccine.2008.12.059 Rennels, 1996, Concurrent oral poliovirus and rhesus-human reassortant rotavirus vaccination: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines, J Infect Dis, 173, 306, 10.1093/infdis/173.2.306 Steele, 2009, Rotavirus vaccines for infants in developing countries in Africa and Asia: considerations from a World Health Organization-sponsored consultation, J Infect Dis, 200, S63, 10.1086/605042 Madhi, 2010, Effect of human rotavirus vaccine on severe diarrhea in African infants, N Engl J Med, 362, 289, 10.1056/NEJMoa0904797 Patel, 2009, Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua, JAMA, 310, 2243, 10.1001/jama.2009.756 2009, Reduction in rotavirus after vaccine introduction—United States, 2000–2009, MMWR Morb Mortal Wkly Rep, 58, 1146 Palma, 2010, Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study, BMJ, 341, c2825, 10.1136/bmj.c2825 2009, Meeting of the immunization Strategic Advisory Group of Experts, April 2009—conclusions and recommendations, Wkly Epidemiol Rec, 84, 220 2009, Rotavirus vaccines: an update, Wkly Epidemiol Rec, 84, 533 Atherly, 2009, Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries, J Infect Dis, 200, S28, 10.1086/605033